The Effect of Everolimus Initiation and Early Calcineurin Inhibitor Withdrawal on Exercise Capacity in De-Novo Heart Transplant Recipients: Results of the SCHEDULE Trial After 36 Months

被引：0
|
作者：
Arora, S. [1 ]
Gude, E. [1 ]
Karason, K. [2 ]
Andersson, B. [2 ]
Bartfay, S. [2 ]
Solbu, D. [3 ]
Dellgren, G. [2 ]
Andreassen, A. [1 ]
Gullestad, L. [1 ]
机构：
[1] Natl Hosp Norway, Oslo Univ Hosp, Cardiol, Oslo, Norway
[2] Sahlgrens Univ Hosp, Cardiol, Gothenburg, Sweden
[3] Novartis Norge, Oslo, Norway
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2017年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
925
引用
收藏
页码：S299 / S299
页数：1
相关论文
共 50 条
  • [1] The Effect of Everolimus Initiation and Early Calcineurin Inhibitor Withdrawal on Allograft Vasculopathy in De-Novo Heart Transplant: Recipients: Results of the SCHEDULE Trial After 36 Months
    Arora, S.
    Solberg, O.
    Karason, K.
    Andersson, B.
    Gustafsson, F.
    Eiskjaer, H.
    Radegran, G.
    Gude, E.
    Ueland, T.
    Aukrust, P.
    Solbu, D.
    Dellgren, G.
    Andreassen, A.
    Gullestad, L.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (04): : S85 - S85
  • [2] Everolimus initiation with early calcineurin inhibitor withdrawal reduced allograft vaculopathy in de-novo heart transplant recipients: results of the SCHEDULE trial
    Arora, S.
    Andersson, B.
    Gustafsson, F.
    Eiskjaer, H.
    Raadegran, G.
    Aaberge, L.
    Erikstad, I.
    Gude, E.
    Solbu, D.
    Gullestad, L.
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 : 179 - 180
  • [3] The Effect of Everolimus Initiation and Early Calcineurin Inhibitor Withdrawal on Allograft Vasculopathy in De-Novo Heart Transplant Recipients: Results of the Schedule Trial after 6 Years
    Arora, S.
    Karason, K.
    Gustafsson, F.
    Eiskjaer, H.
    Radegran, G.
    Aaberge, L.
    Gude, E.
    Solbu, D.
    Dellgren, G.
    Andreassen, A. K.
    Gullestad, L.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S36 - S36
  • [4] Everolimus Initiation With Calcineurin Inhibitor Withdrawal Reduces Allograft Vasculopathy in De-Novo Heart Transplant Recipients
    Arora, S.
    Andersson, B.
    Gustafsson, E.
    Eiskjaer, H.
    Radegran, G.
    Aaberge, L.
    Erikstad, I.
    Gude, E.
    Ueland, T.
    Aukrust, P.
    Solbu, D.
    Dellgren, G.
    Andreassen, A.
    Gullestad, L.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : S154 - S154
  • [5] Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Three-Year Results From the Randomized SCHEDULE Study
    Andreassen, A. K.
    Andersson, B.
    Gustafsson, F.
    Eiskjaer, H.
    Radegran, G.
    Gude, E.
    Jansson, K.
    Solbu, D.
    Karason, K.
    Arora, S.
    Dellgren, G.
    Gullestad, L.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 (04) : 1238 - 1247
  • [6] Everolimus Initiation and Early Calcineurin Inhibitor Withdrawal in Heart Transplant Recipients: A Randomized Trial
    Andreassen, A. K.
    Andersson, B.
    Gustafsson, F.
    Eiskjaer, H.
    Rdegran, G.
    Gude, E.
    Jansson, K.
    Solbu, D.
    Sigurdardottir, V.
    Arora, S.
    Dellgren, G.
    Gullestad, L.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (08) : 1828 - 1838
  • [7] Three Year Follow Up of the Randomized SCHEDULE Trial With Everolimus Initiation and Early Withdrawal of Calcineurin Inhibitor Therapy in De Novo Heart Transplant Recipients - A Multicenter, Randomized Scandinavian Trial
    Andreassen, A. K.
    Andersson, B.
    Gustafsson, F.
    Eiskjaer, H.
    Radegran, G.
    Gude, E.
    Jansson, K.
    Solbu, D.
    Karason, K.
    Arora, S.
    Dellgren, G.
    Gullestad, I.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (04): : S129 - S130
  • [8] Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Long-term Follow-up From the Randomized SCHEDULE Study
    Gustafsson, Finn
    Andreassen, Arne K.
    Andersson, Bert
    Eiskjaer, Hans
    Radegran, Goran
    Gude, Einar
    Jansson, Kjell
    Solbu, Dag
    Karason, Kristjan
    Arora, Satish
    Dellgren, Goran
    Gullestad, Lars
    [J]. TRANSPLANTATION, 2020, 104 (01) : 154 - 164
  • [9] Scandinavian Heart Transplant Everolimus De Novo Study with Early Calcineurin Inhibitor Avoidance (SCHEDULE)
    Andreassen, A. K.
    Gude, E.
    Sigurdardottir, V.
    Dellgren, G.
    Andersson, B.
    Ekmehag, B.
    Radegran, G.
    Jansson, K.
    Gustafsson, F.
    Eiskjaer, H.
    Solbu, D.
    Gullestad, L.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (04): : S134 - S134
  • [10] Exercise Capacity in De-Novo Heart Transplant Recipents With Everolimus Vs Conventional CNI Based Immunosuppresion. The Results of a Randomized Trial (SCHEDULE)
    Gude, E.
    Bartfay, S.
    Andersson, B.
    Sigurdardottir, V.
    Stueflotten, W.
    Gullestad, L.
    Andreassen, A.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : S134 - S134
12345